Save your place

Sign in to WhoBought

Please try again later.

Jim Simons's Grace Therapeutics, Inc. (GRCE) position

Yes: as of Q1 2026, Jim Simons holds 244K shares of GRCE worth an amount we cannot price (0.0% of the disclosed portfolio). Last quarter the position was increased by 87.9%. First disclosed Q4 2024.
View full portfolio →
Current value
an amount we cannot price
Shares held
244K
% of portfolio
0.0%
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

GRCE price vs Simons's position

Dates
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Added +114K +87.9% 244K May 14, 2026
Q4 2025 Added +45K +53.5% 130K Feb 12, 2026
Q3 2025 Added +57K +206.1% 85K Nov 13, 2025
Q2 2025 Reduced −15K −34.5% 28K Aug 13, 2025
Q1 2025 Reduced −794 −1.8% 42K May 14, 2025
Q4 2024 New +43K 43K Feb 13, 2025
Data through Q1 2026 · filed May 14, 2026
6 grouped rows from 6 quarters

More Simons positions

Common questions

Does Jim Simons own GRCE?

Yes. As of Q1 2026, Jim Simons disclosed 244K shares of GRCE, worth an amount we cannot price. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jim Simons buy GRCE?

Jim Simons first disclosed a GRCE position in Q4 2024; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jim Simons sell GRCE?

The quarter-by-quarter table above shows each sale and reduction Jim Simons disclosed in GRCE. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of GRCE does Jim Simons own?

Jim Simons disclosed 244K shares of GRCE as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jim Simons pay for GRCE?

Jim Simons began building the GRCE position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.